Showing results (981-990 of 5,050) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|December 5, 2025
Transverse myelitis following COVID-19 infection or vaccination: Clinical outcomes and imaging characteristics compared with idiopathic casesJi-Yon Kim, Hee-Jae Jung, Shina Kim, et al.
Multiple Sclerosis and Related Disorders|December 5, 2025
Sex differences in multiple sclerosis treatment with disease modifying drugs: a step towards gender neurologyLudovico Baiamonte, Marco Enea, Marco Vaccaro, et al.
Multiple Sclerosis and Related Disorders|December 1, 2025
Auditory test of processing speed: Further validation and test-retest reliabilityJacob Balconi, Michael Jaworski, Omid Mirmosayyeb, et al.
Multiple Sclerosis and Related Disorders|November 28, 2025
Discrepancies between subjective and objective cognition in persons with multiple sclerosis: Exploring the role of cannabis useAnne Kever, Anthony Feinstein
Multiple Sclerosis and Related Disorders|January 21, 2026
Exposure to tobacco smoke during pregnancy and the risk of multiple sclerosis in offspring: A systematic review and meta-analysisMohamed Ezzat M Mansour, Omar Kassar, Khalid Radwan Alsaadany, et al.
Multiple Sclerosis and Related Disorders|January 24, 2026
Cognitive reserve and its contribution to predicting cognitive performance in multiple sclerosisSadra Habibi Moini, Majid Hamidi, Ali Rezaei, et al.
Multiple Sclerosis and Related Disorders|January 20, 2026
Efficacy of fresh frozen plasma and human albumin in therapeutic plasma exchange for refractory neuromyelitis optica spectrum disorders and multiple sclerosis exacerbation: A two-tertiary care center studyBhume Kanokvichitra, Chutithep Teekaput, Kitti Thiankhaw, et al.
Multiple Sclerosis and Related Disorders|January 17, 2026
Characterizing spinal cord atrophy in multiple sclerosis patients without disease activity or brain atrophy progressionHiroaki Yokote, Yusei Miyazaki, Juichi Fujimori, et al.
Multiple Sclerosis and Related Disorders|January 23, 2026
Virus antibody responses in patients with myelin oligodendrocyte glycoprotein antibody-associated disease and multiple sclerosisJ L Frederiksen, D Žiogienė, R Slibinskas, et al.
Multiple Sclerosis and Related Disorders|January 22, 2026
Polypharmacy prevalence, associated factors, and changes over time in Australians with multiple sclerosisTing Zhao, Hasnat Ahmad, Huah Shin Ng, et al.
Pageof 505